Abbas H, Gad HA, Khattab MA, Mansour M (2021) The tragedy of Alzheimer’s disease: towards better management via resveratrol-loaded oral bilosomes. Pharmaceutics 13. https://doi.org/10.3390/pharmaceutics13101635
Abdallah HM, El Sayed NS, Sirwi A et al (2021) Mangostanaxanthone IV ameliorates streptozotocin-induced neuro-inflammation, amyloid deposition, and Tau hyperphosphorylation via modulating PI3K/Akt/GSK-3β pathway. Biology (Basel) 10. https://doi.org/10.3390/biology10121298
Agrawal R, Tyagi E, Shukla R, Nath C (2008) Effect of insulin and melatonin on acetylcholinesterase activity in the brain of amnesic mice. Behav Brain Res 189:381–386. https://doi.org/10.1016/j.bbr.2008.01.015
Article CAS PubMed Google Scholar
Alesiani D, Ciccon R, Mattei M et al (2009) Inhibition of Mek 1 / 2 kinase activity and stimulation of melanogenesis by 5, 7-dimethoxycoumarin treatment of melanoma cells. Int J Oncol 34:1727–1735. https://doi.org/10.3892/ijo
Article CAS PubMed Google Scholar
Ali MY, Jannat S, Jung HA et al (2016) Anti-Alzheimer’s disease potential of coumarins from Angelica decursiva and Artemisia capillaris and structure-activity analysis. Asian Pac J Trop Med 9:103–111. https://doi.org/10.1016/j.apjtm.2016.01.014
Article CAS PubMed Google Scholar
Amaral AC, Perez-Nievas BG, Siao Tick Chong M et al (2021) Isoform-selective decrease of glycogen synthase kinase-3-beta (GSK-3β) reduces synaptic Tau phosphorylation, transcellular spreading, and aggregation. https://doi.org/10.1016/j.isci.2021.102058. iScience 24:
Ashabi G, Ramin M, Azizi P et al (2012) ERK and p38 inhibitors attenuate memory deficits and increase CREB phosphorylation and PGC-1α levels in Aβ-injected rats. Behav Brain Res 232:165–173. https://doi.org/10.1016/j.bbr.2012.04.006
Article CAS PubMed Google Scholar
Brightwell JJ, Smith CA, Countryman RA et al (2005) Hippocampal overexpression of mutant Creb blocks long-term, but not short-term memory for a socially transmitted food preference. Learn Mem 12:12–17. https://doi.org/10.1101/lm.85005
Article PubMed Central PubMed Google Scholar
Burillo J, Marqués P, Jiménez B et al (2021) Insulin resistance and diabetes mellitus in Alzheimer’s disease. Cells 10. https://doi.org/10.3390/cells10051236
Chen J, Niu Q, Xia T et al (2018) ERK1/2-mediated disruption of BDNF–TrkB signaling causes synaptic impairment contributing to fluoride–induced developmental neurotoxicity. Toxicology 410:222–230. https://doi.org/10.1016/j.tox.2018.08.009
Article CAS PubMed Google Scholar
Chen L, Feng P, Peng A et al (2020) Protective effects of isoquercitrin on streptozotocin-induced neurotoxicity. J Cell Mol Med 24:10458–10467. https://doi.org/10.1111/jcmm.15658
Article CAS PubMed Central PubMed Google Scholar
Cherubini E, Miles R (2015) The CA3 region of the hippocampus: how is it? What is it for? how does it do it? Front Cell Neurosci 9:9–11. https://doi.org/10.3389/fncel.2015.00019
Chowdhury AA, Gawali NB, Shinde P et al (2018) Imperatorin ameliorates lipopolysaccharide induced memory deficit by mitigating Proinflammatory cytokines, oxidative stress and modulating brain-derived neurotropic factor. Cytokine 110:78–86. https://doi.org/10.1016/j.cyto.2018.04.018
Article CAS PubMed Google Scholar
Chuang D-M, Wang Z, Chiu C-T (2011) GSK-3 as a target for Lithium-Induced neuroprotection against excitotoxicity in neuronal cultures and animal models of ischemic stroke. Front Mol Neurosci 4:1–12. https://doi.org/10.3389/fnmol.2011.00015
Cognato G, de Bortolotto P, Blazina JW AR, et al (2012) Y-Maze memory task in zebrafish (Danio rerio): The role of glutamatergic and cholinergic systems on the acquisition and consolidation periods. Neurobiol Learn Mem 98:321–328. https://doi.org/10.1016/j.nlm.2012.09.008
Article CAS PubMed Google Scholar
Corasaniti MT, Maiuolo J, Maida S et al (2007) Cell signaling pathways in the mechanisms of neuroprotection afforded by Bergamot essential oil against NMDA-induced cell death in vitro. Br J Pharmacol 151:518–529. https://doi.org/10.1038/sj.bjp.0707237
Article CAS PubMed Central PubMed Google Scholar
Correa F, Hernangómez M, Mestre L et al (2010) Anandamide enhances IL-10 production in activated microglia by targeting CB2 receptors: roles of ERK1/2, JNK, and NF-κB. Glia 58:135–147. https://doi.org/10.1002/glia.20907
D’Hooge R, De Deyn PP (2001) Applications of the Morris water maze in the study of learning and memory. Brain Res Brain Res Rev 36:60–90. https://doi.org/10.1016/s0165-0173(01)00067-4
De Araújo AB, Azul FVCS, Silva FRM et al (2022) Antineuroinflammatory effect of Amburana cearensis and its molecules coumarin and Amburoside A by inhibiting the MAPK signaling pathway in LPS-Activated BV-2 microglial cells. https://doi.org/10.1155/2022/6304087. Oxid Med Cell Longev 2022:
Di Paola R, Galuppo M, Mazzon E et al (2010) PD98059, a specific MAP kinase inhibitor, attenuates multiple organ dysfunction syndrome/failure (MODS) induced by zymosan in mice. Pharmacol Res 61:175–187. https://doi.org/10.1016/j.phrs.2009.09.008
Article CAS PubMed Google Scholar
Dillon C, Serrano CM, Castro D et al (2013) Behavioral symptoms related to cognitive impairment. Neuropsychiatr Dis Treat 9:1443–1455. https://doi.org/10.2147/NDT.S47133
Article PubMed Central PubMed Google Scholar
El Tabaa MM, Sokkar SS, Ramdan ES et al (2022) Does (–)-epigallocatechin-3-gallate protect the neurotoxicity induced by bisphenol A in vivo? Environ Sci Pollut Res 29:32190–32203. https://doi.org/10.1007/s11356-021-18408-z
Epifano F, Pelucchini C, Curini M, Genovese S (2009) Insights on novel biologically active natural products: 7-Isopentenyloxycoumarin. Nat Prod Commun 4:1755–1760. https://doi.org/10.1177/1934578x0900401228
Article CAS PubMed Google Scholar
Fang X, Yu SX, Lu Y et al (2000) Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A. Proc Natl Acad Sci U S A 97:11960–11965. https://doi.org/10.1073/pnas.220413597
Article CAS PubMed Central PubMed Google Scholar
Folch J, Ettcheto M, Busquets O et al (2018) The implication of the brain insulin receptor in late onset Alzheimer’s disease dementia. Pharmaceuticals 11:1–16. https://doi.org/10.3390/ph11010011
Fronza MG, Baldinotti R, Martins MC et al (2019) Rational design, cognition and neuropathology evaluation of QTC-4-MeOBnE in a streptozotocin-induced mouse model of sporadic Alzheimer’s disease. Sci Rep 9:1–14. https://doi.org/10.1038/s41598-019-43532-9
Gargiulo S, Greco A, Gramanzini M et al (2012) Mice anesthesia, analgesia, and care, part I: anesthetic considerations in preclinical research. ILAR J 53. https://doi.org/10.1093/ilar.53.1.55
Giese KP (2009) GSK-3: A key player in neurodegeneration and memory. IUBMB Life 61:516–521
Article CAS PubMed Google Scholar
Grieb P (2016) Intracerebroventricular streptozotocin injections as a model of Alzheimer’s disease: in search of a relevant mechanism. Mol Neurobiol 53:1741–1752. https://doi.org/10.1007/s12035-015-9132-3
Article CAS PubMed Google Scholar
Grimes CA, Jope RS (2001) Creb DNA binding activity is inhibited by glycogen synthase kinase-3β and facilitated by lithium. J Neurochem 78:1219–1232. https://doi.org/10.1046/j.1471-4159.2001.00495.x
Article CAS PubMed Central PubMed Google Scholar
Harrison JF, Rinne ML, Kelley MR et al (2007) Altering DNA base excision repair: use of nuclear and mitochondrial-targeted N-methylpurine DNA glycosylase to sensitize astroglia to chemotherapeutic agents. Glia 55:1416–1425. https://doi.org/10.1002/glia.20556
Article PubMed Central PubMed Google Scholar
Honig LS, Barakos J, Dhadda S et al (2023) ARIA in patients treated with Lecanemab (BAN2401) in a phase 2 study in early Alzheimer’s disease. Alzheimer’s Dement Transl Res Clin Interv 9:1–12. https://doi.org/10.1002/trc2.12377
Hoppe JB, Frozza L, Horn AP et al (2010) Amyloid- B neurotoxicity in organotypic culture is attenuated by melatonin: involvement of GSK-3 B, Tau and neuroinflammation. 48:230–238. https://doi.org/10.1111/j.1600-079X.2010.00747.x
Ishii A, Furusho M, Dupree JL, Bansal R (2016) Strength of ERK1/2 MAPK activation determines its effect on Myelin and axonal integrity in the adult CNS. J Neurosci 36:6471–6487. https://doi.org/10.1523/JNEUROSCI.0299-16.2016
Comments (0)